Ascendis Pharma (ASND) PT Raised to $224 at Oppenheimer
Tweet Send to a Friend
(Updated - June 13, 2025 6:00 AM EDT)
Oppenheimer analyst Leland Gershell raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
